KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (ONC) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $1.7 billion.

  • BeOne Medicines' Other Gross PP&E Adjustments rose 19762.66% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 19762.66%. This contributed to the annual value of $491.8 million for FY2024, which is 175261.78% up from last year.
  • Per BeOne Medicines' latest filing, its Other Gross PP&E Adjustments stood at $1.7 billion for Q3 2025, which was up 19762.66% from $1.2 billion recorded in Q2 2025.
  • BeOne Medicines' 5-year Other Gross PP&E Adjustments high stood at $1.7 billion for Q3 2025, and its period low was -$29.8 million during Q4 2023.
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was $250.8 million (2023), whereas its average is $388.2 million.
  • As far as peak fluctuations go, BeOne Medicines' Other Gross PP&E Adjustments crashed by 11672.51% in 2024, and later surged by 454586.25% in 2025.
  • Over the past 5 years, BeOne Medicines' Other Gross PP&E Adjustments (Quarter) stood at $205.8 million in 2021, then soared by 46.02% to $300.5 million in 2022, then crashed by 109.9% to -$29.8 million in 2023, then surged by 1752.62% to $491.8 million in 2024, then surged by 248.34% to $1.7 billion in 2025.
  • Its Other Gross PP&E Adjustments stands at $1.7 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $696.6 million for Q1 2025.